Cover Image
市場調查報告書

全球流式細胞技術市場 - 市場機會、預測:2014-2022年

World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 344778
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球流式細胞技術市場 - 市場機會、預測:2014-2022年 World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022
出版日期: 2015年10月01日 內容資訊: 英文 166 Pages
簡介

流式細胞技術,是透過照射雷射光線,檢測、分析液體中浮游的細胞或粒子相關的幾個物理特性,使用雷射的生物物理學的分析技術。流式細胞技術相對於ELISA等傳統的分析方法,能以幾乎同等價格,花更少的時間提供正確的結果等,具有許多優勢點。流式細胞技術技術,廣泛用於多樣學術、臨床研究的領域,以及癌症、HIV及惡性血液疾病等的診斷。患HIV及癌症的患者數增加,和醫院及診療中心的流式細胞技術的利用擴大,產生有效診斷疾病及監測中流式細胞技術緊急的必要性。全球流式細胞技術市場,預計2022年達到70億美元的規模。

本報告以全球流式細胞技術市場為主題,提供市場概要、市場發展促進與阻礙因素、市場機會,以及法規的問題、各零件、各技術、各用途/地區的市場現況與展望相關調查分析、主要的供應商簡介彙整。

第1章 簡介

  • 關於本報告
  • 主要的成果
  • 調查手法

第2章 摘要整理

  • CXO的觀點

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 最大影響要素
    • 最重要投資處領域
    • 最重要策略
  • 波特的五力分析
  • 市場佔有率分析,2014年
  • 償付方案
  • 法規問題
    • 取得FDA認證的課題
    • ASR規則的影響
    • 檢驗的課題:以細胞為基礎
    • 檢驗必要條件 (CLIP,CAP)
    • 以細胞為基礎的螢光分子冷光相關LDT指南
    • 法規的變更
  • 推動市場成長要素
    • 技術發展
    • 研究、診斷用途的流式細胞技術的大規模採用
    • 在新領域的用途擴大
    • 研究開發投資的增加
    • HIV及癌症的患病數量上升
  • 阻礙市場成長要素
    • 器具成本高
    • 消費者缺乏認識
    • 技術性專門知識的規定
  • 市場機會
    • 診斷中利益的機會
    • 藥物研發及醫藥品開發中流式細胞技術的新作用

第4章 全球流式細胞技術市場,各零件,2014-2022年

  • 概要
    • 市場規模、預測
  • 器具
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
    • 平台
      • 市場規模、預測
        • 分類器
        • 分析器
    • 可替換零組件
      • 市場規模、預測
      • 過濾器
      • 雷射
      • 檢測器
      • 其他
    • 配件
      • 市場規模、預測
  • 試劑、消耗品
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
    • 抗體
      • 市場規模、預測
    • 染料
      • 市場規模、預測
      • 市場規模、預測
    • 其他
      • 市場規模、預測
  • 軟體
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 服務
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測

第5章 全球流式細胞技術市場,各技術,2014-2022年

  • 概要
    • 市場規模、預測
  • 以微珠為基礎的流式細胞技術
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 以細胞為基礎的流式細胞技術
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測

第6章 全球流式細胞技術市場,各用途,2014-2022年

  • 概要
    • 市場規模、預測
  • 學術、臨床用途
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
    • 細胞週期分析和細胞增生
      • 市場規模、預測
    • 細胞凋亡
      • 市場規模、預測
    • 分類/篩檢
      • 市場規模、預測
    • 轉染、細胞生存
      • 市場規模、預測
    • 其他
      • 市場規模、預測
  • 診斷用途
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
    • 器官移植
      • 市場規模、預測
    • 惡性血液疾病
      • 市場規模、預測
    • 癌症、固態腫瘤
      • 市場規模、預測
    • HIV
      • 市場規模、預測
    • 其他
      • 市場規模、預測

第7章 全球流式細胞技術市場,各終端用戶,2014-2022年

  • 概要
    • 市場規模、預測
  • 商業組織
    • 主要的市場趨勢
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 醫學專門學校、臨床檢驗研究所
    • 主要的市場趨勢
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 醫院
    • 主要的市場趨勢
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 學術機構
    • 主要的市場趨勢
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 其他
    • 市場規模、預測

第8章 全球流式細胞技術市場,各地區中,2014-2022年

  • 概要
    • 市場規模、預測
  • 北美
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 歐洲
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • 亞太地區
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測
  • LAMEA (南美、中東、非洲)
    • 主要的市場趨勢
    • 競爭情形
    • 主要的成長要素與市場機會
    • 市場規模、預測

第9章 企業簡介 (企業概要、概況、營運產業部門、業績、主要策略的趨勢、SWOT分析)

  • Danaher Corporation (Beckman Coulter)
  • Affymetrix, Inc.
  • Sysmex Corporation
  • Becton, Dickinson and Co.
  • Merck Millipore
  • Luminex Corporation
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec, GmbH.
  • Dako (Agilent Technologies)

圖表清單

目錄

Title: World Flow Cytometry Market by Product (Accessories, Services, Software, Reagents, Consumables, FC Instruments), Technology (Cell Based, Bead-Based) and Application (Apoptosis, Cell Cycle Analysis, Cell sorting, Cell Viability, Organ transplantation, Cancer, Immunodeficiency Disease, Hematology Haematological Malignancies) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022.

Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases.

World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the market growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.

The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period. The report segments the world flow cytometry market based on components, technologies, applications, end users and geography. Based on components, the market is segmented into instruments, reagents, software and services. Instruments accounted for the highest revenue-generating segment in 2014, owing to the technological advancements, demand for highly efficient replaceable components and widening scope of flow cytometry applications in newer diseases. Based on technology, the market is segmented into bead based and cell based technologies. Cell based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. Based on application, world flow cytometry market is segmented into academic and clinical research, and diagnostic applications. Academic and clinical research application was the major revenue generating segment in 2014, however, diagnostics segment is projected as the fastest growing segment. The world flow cytometry end users market is segmented into commercial organizations, medical schools and research labs, hospitals, academics and others. Commercial organizations was the highest revenue generating end-user segment in 2014, due to high adoption of flow cytometry in drug discovery process and clinical research.

Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America was the leading region in 2014, supplemented by rapid technological advancements, high R&D investment and widespread use of flow cytometry in research and diagnostic activities. Asia Pacific region would emerge as the most lucrative market over the forecast period owing to outsourcing of R&D activities in this region and increasing incidences of diseases such as cancer and HIV.

The report provides a comprehensive analysis of the leading companies operating in the world flow cytometry market. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company , EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.

KEY MARKET BENEFITS:

  • The study provides an in-depth analysis of the world flow cytometry market with current and future trends to elucidate the imminent investment pockets in the market.
  • The report provides a quantitative analysis through 2014-2022, which would enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the world flow cytometry market, by component, helps in understanding the components of the flow cytometer that are currently used along with the variants that would gain prominence in the future
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies
  • SWOT analysis enables to study the internal and external environment of the leading companies for strategy formulation

KEY MARKET SEGMENTS:

The world flow cytometry market is segmented as:

  • World Flow Cytometry Market By Component
    • Instruments
      • Cytometry platforms
        • Sorters
        • Analyzers
    • Replaceable components
      • Filter
      • Laser
      • Detectors
      • Others
    • Accessories
    • Reagents and consumables
      • Antibodies
      • Dyes
      • Beads
      • Solutions
      • Buffers
      • Others
    • Software
    • Services
  • World Flow Cytometry Market By Technology
    • Bead based flow cytometry
    • Cell based flow cytometry
  • World Flow Cytometry Market By Application
    • Academic and clinical research applications
      • Cell cycle analysis and cell proliferation
      • Apoptosis
      • Sorting and screening
      • Transfection and cell viability
      • Others
    • Diagnosis applications
      • Organ transplantation
      • Hematological malignancies
      • Cancer and solid tumors
      • Immunodeficiency diseases- HIV infection
      • Others
  • World Flow Cytometry Market By End users
    • Commercial organizations
    • Medical schools and clinical labs
    • Hospitals
    • Academics
    • Others
  • World Flow Cytometry Market By Geography
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Research methodology
    • 1.3.1. Secondary research
  • 1.4. Primary research
    • 1.4.1. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
    • 3.2.3. Top winning strategies
  • 3.3. Porters five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. High bargaining power of buyers
    • 3.3.3. Low threat of new entrants
    • 3.3.4. High competitive rivalry
    • 3.3.5. Low threat of substitutes
  • 3.4. Market share analysis, 2014
  • 3.5. Reimbursement scenario
  • 3.6. Regulatory issues
    • 3.6.1. Challenges in FDA clearance
    • 3.6.2. Impact of ASR rule
    • 3.6.3. Validation challenges: cellbased
    • 3.6.4. Validation requirements (CLIA, CAP)
    • 3.6.5. LDT guidelines on cellbased fluorescence
    • 3.6.6. Change in regulations
  • 3.7. Drivers
    • 3.7.1. Technological advancements
    • 3.7.2. Large scale adoption of flow cytometry technique in research and diagnosis applications
    • 3.7.3. Increasing applications across novel fields
    • 3.7.4. Augmented R&D investment
    • 3.7.5. Rising incidences of HIV and cancer
  • 3.8. Restraints
    • 3.8.1. High cost of instrument
    • 3.8.2. Lack of awareness among consumers
    • 3.8.3. Limited technical expertise
  • 3.9. Opportunities
    • 3.9.1. Lucrative opportunities in diagnostics
    • 3.9.2. Emerging role of flow cytometry in drug discovery and development

CHAPTER 4: WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Instruments
    • 4.2.1. Key market trends
    • 4.2.2. Competitive landscape
    • 4.2.3. Key growth factors and opportunities
    • 4.2.4. Market size and forecast
    • 4.2.5. Platforms
      • 4.2.5.1. Market size and forecast
      • 4.2.5.2. Sorters
        • 4.2.5.2.1. MARKET SIZE AND FORECAST
      • 4.2.5.3. Analysers
        • 4.2.5.3.1. MARKET SIZE AND FORECAST
    • 4.2.6. Replaceable components
      • 4.2.6.1. Market size and forecast
      • 4.2.6.2. Filters
        • 4.2.6.2.1. MARKET SIZE AND FORECAST
      • 4.2.6.3. Lasers
        • 4.2.6.3.1. MARKET SIZE AND FORECAST
      • 4.2.6.4. Detectors
        • 4.2.6.4.1. MARKET SIZE AND FORECAST
      • 4.2.6.5. Others
        • 4.2.6.5.1. MARKET SIZE AND FORECAST
    • 4.2.7. Accessories
      • 4.2.7.1. Market size and forecast
  • 4.3. Reagents and consumables
    • 4.3.1. Competitive landscape
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Antibodies
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Dyes
      • 4.3.5.1. Market size and forecast
    • 4.3.6. Beads
      • 4.3.6.1. Market size and forecast
    • 4.3.7. Others
      • 4.3.7.1. MArket size and forecast
  • 4.4. Software
    • 4.4.1. Key market trends
    • 4.4.2. Competitive landscape
    • 4.4.3. Key growth factors and opportunities
    • 4.4.4. Market size and forecast
  • 4.5. Services
    • 4.5.1. Key market trends
    • 4.5.2. Competitive landscape
    • 4.5.3. Key growth factors and opportunities
    • 4.5.4. Market size and forecast

CHAPTER 5: WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-2022

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Bead-based flow cytometry
    • 5.2.1. Key market trends
    • 5.2.2. Competitive landscape
    • 5.2.3. Key growth factors and opportunities
    • 5.2.4. Market size and forecast
  • 5.3. Cell based flow cytometers
    • 5.3.1. Key market trends
    • 5.3.2. Competitive landscape
    • 5.3.3. Key growth factors and opportunities
    • 5.3.4. Market size and forecast

CHAPTER 6: WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-2022

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Academic and clinical applications
    • 6.2.1. Key market trends
    • 6.2.2. Competitive landscape
    • 6.2.3. Key growth factors and opportunities
    • 6.2.4. Market size and forecast
    • 6.2.5. Cell cycle analysis and cell proliferation
      • 6.2.5.1. Market size and forecast
    • 6.2.6. Apoptosis
      • 6.2.6.1. Market size and forecast
    • 6.2.7. Sorting/Screening
      • 6.2.7.1. Market size and forecast
    • 6.2.8. Transfection and cell viability
      • 6.2.8.1. Market size and forecast
    • 6.2.9. Others
      • 6.2.9.1. Market size and forecast
  • 6.3. Diagnostic applications
    • 6.3.1. Key market trends
    • 6.3.2. Competitive landscape
    • 6.3.3. Key growth factors and opportunities
    • 6.3.4. Market size and forecast
    • 6.3.5. Organ transplantation
      • 6.3.5.1. Market size and forecast
    • 6.3.6. Hematological malignancies
      • 6.3.6.1. Market size and forecast
    • 6.3.7. Cancer and solid tumor
      • 6.3.7.1. Market size and forecast
    • 6.3.8. HIV
      • 6.3.8.1. Market size and forecast
    • 6.3.9. Others
      • 6.3.9.1. Market size and forecast

CHAPTER 7: WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-2022

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Commercial organizations
    • 7.2.1. Key market trends
    • 7.2.2. Key growth factors and opportunities
    • 7.2.3. Market size and forecast
  • 7.3. Medical schools and clinical testing labs
    • 7.3.1. Key market trends
    • 7.3.2. Key growth factors and opportunities
    • 7.3.3. Market size and forecast
  • 7.4. Hospitals
    • 7.4.1. Key market trends
    • 7.4.2. Key growth factors and opportunities
    • 7.4.3. Market size and forecast
  • 7.5. Academic institutions
    • 7.5.1. Key market trends
    • 7.5.2. Key growth factors and opportunities
    • 7.5.3. Market size and forecast
  • 7.6. Others
    • 7.6.1. Market size and forecast

CHAPTER 8: WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. North America
    • 8.2.1. Key market trends
    • 8.2.2. Competitive landscape
    • 8.2.3. Key growth factors and opportunities
    • 8.2.4. Market size and forecast
  • 8.3. Europe
    • 8.3.1. Key market trends
    • 8.3.2. Competitive landscape
    • 8.3.3. Key growth factors and opportunities
    • 8.3.4. Market size and forecast
  • 8.4. Asia Pacific
    • 8.4.1. Key market trends
    • 8.4.2. Competitive landscape
    • 8.4.3. Key growth factors and opportunities
    • 8.4.4. Market size and forecast
  • 8.5. LAMEA
    • 8.5.1. Key market trends
    • 8.5.2. Competitive landscape
    • 8.5.3. Key growth factors and opportunities
    • 8.5.4. Market size and forecast

CHAPTER 9: COMPANY PROFILES

  • 9.1. Danaher Corporation (Beckman Coulter)
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Operating business segments
    • 9.1.4. Business performance
    • 9.1.5. Key strategic moves and developments
    • 9.1.6. SWOT analysis
  • 9.2. Affymetrix, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Operating business segments
    • 9.2.4. Business performance
    • 9.2.5. Key strategic moves and developments
    • 9.2.6. SWOT analysis
  • 9.3. Sysmex Corporation
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Operating business segments
    • 9.3.4. Business performance
    • 9.3.5. Key strategic moves and developments
    • 9.3.6. SWOT Analysis
  • 9.4. Becton, Dickinson and Co.
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Business performance
    • 9.4.5. Key strategic moves and developments
    • 9.4.6. SWOT analysis
  • 9.5. Merck Millipore
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Business performance
    • 9.5.4. Key strategic moves and developments
    • 9.5.5. SWOT analysis
  • 9.6. Luminex Corporation
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Business performance
    • 9.6.5. Key strategic moves and developments
    • 9.6.6. SWOT Analysis
  • 9.7. Thermo Fisher Scientific
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Operating business segment
    • 9.7.4. Business performance
    • 9.7.5. Key strategic moves and developments
    • 9.7.6. SWOT analysis
  • 9.8. Bio-Rad Laboratories, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Operating business segments
    • 9.8.4. Business performance
    • 9.8.5. Key strategic moves and developments
    • 9.8.6. SWOT analysis
  • 9.9. Miltenyi Biotec, GmbH.
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Operating business segments
    • 9.9.4. Business performance
    • 9.9.5. Key strategic moves and developments
    • 9.9.6. SWOT analysis.
  • 9.10. Dako (Agilent Technologies)
    • 9.10.1. Company overview
    • 9.10.2. Company snapshot
    • 9.10.3. Operating business segments
    • 9.10.4. Business performance
    • 9.10.5. Key strategic moves and developments
    • 9.10.6. SWOT analysis

List of Tables

  • TABLE 1: WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)
  • TABLE 2: WORLD FLOW CYTOMETRY MARKET, BY INSTRUMENTS, 2014-2022 ($MILLION)
  • TABLE 3: WORLD FLOW CYTOMETRY INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 4: WORLD FLOW CYTOMETRY INSTRUMENT MARKET, BY PLATFORMS, 2014-2022 ($MILLIONS)
  • TABLE 5: WORLD FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 6: TYPES OF PLATFORM
  • TABLE 7: TYPES OF SORTERS
  • TABLE 8: WORLD FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 9: WORLD FLOW CYTOMETRY ANALYZERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 10: ANALYZERS BY KEY PLAYERS
  • TABLE 11: WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY TYPES, 2014-2022 ($MILLION)
  • TABLE 12: WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 13: TYPES OF FILTERS
  • TABLE 14: WORLD FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 15: WORLD FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 16: TYPES OF DETECTORS
  • TABLE 17: WORLD FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 18: WORLD FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 19: WORLD FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 20: WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 21: WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 22: WORLD FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 23: WORLD FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 24: WORLD FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 25: WORLD FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 26: WORLD FLOW CYTOMETRY SOFTWARE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 27: WORLD FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 28: WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
  • TABLE 29: WORLD BEAD BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 30: WORLD CELL BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 31: WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 32: WORLD FLOW CYTOMETRY APPLICATION MARKET, BY ACADEMIC AND CLINICAL RESEARCH APPLICATION, 2014-2022 ($MILLION)
  • TABLE 33: WORLD FLOW CYTOMETRY ACADEMIC AND CLINICAL RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 34: WORLD FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION APPLICATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 35: WORLD FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 36: WORLD FLOW CYTOMETRY SORTING/SCREENING, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 37: WORLD FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 38: WORLD FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 39: WORLD FLOW CYTOMETRY MARKET, BY DIAGNOSTIC APPLICATION, 2014-2022 ($MILLION)
  • TABLE 40: WORLD FLOW CYTOMETRY DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 41: WORLD FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 42: WORLD FLOW CYTOMETRY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 43: WORLD FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 44: WORLD FLOW CYTOMETRY HIV INFECTION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 45: WORLD FLOW CYTOMETRY OTHER DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 46: WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 47: WORLD FLOW CYTOMETRY COMMERCIAL ORGANIZATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 48: WORLD FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 49: WORLD FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 50: WORLD FLOW CYTOMETRY ACADEMIC INSTITUTION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 51: WORLD FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 52: WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
  • TABLE 53: NORTH AMERICA FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)
  • TABLE 54: EUROPE FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
  • TABLE 55: ASIA PACIFIC FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
  • TABLE 56: LAMEA FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
  • TABLE 57: COMPANY SNAPSHOT OF DANAHER CORPORATION
  • TABLE 58: DANAHER CORPORATION OPERATING SEGMENTS
  • TABLE 59: COMPANY SPANSHOT OF AFFYMETRIX, INC.
  • TABLE 60: AFFYMETIX INC., OPERATING SEGMENTS
  • TABLE 61: SNAPSHOT OF SYSMEX CORPORATION
  • TABLE 62: SYSMEX CORPORATION, OPERATING SEGMENTS
  • TABLE 63: COMPANY SNAPSHOT OF BECTON, DICKINSON AND COMPANY
  • TABLE 64: BECTON , DICKINSON AND COMPANY OPERATING SEGMENTS
  • TABLE 65: SNAPSHOT OF MERCK MILLIPORE
  • TABLE 66: COMPANY SNAPSHOT OF LUMINEX CORPORATION
  • TABLE 67: LUMINEX CORPORATION OPERATING SEGMENTS
  • TABLE 68: COMPANY SNAPSHOT THERMO FISHER SCIENTIFIC INC
  • TABLE 69: THERMO FISHER SCIENTIFIC INC. OPERATING SEGMENTS
  • TABLE 70: COMPANY SNAPSHOT OF BIO-RAD LABORATORIES, INC.
  • TABLE 71: BIO-RAD LABORATORIES, INC. OPERATING SEGMENTS
  • TABLE 72: COMPANY SNAPSHOT OF MILTENYI BIOTEC GMBH.
  • TABLE 73: MILTENYI BIOTEC, GMBH. OPERATING SEGMENTS
  • TABLE 74: COMPANY SNAPSHOT OF AGILENT TECHNOLOGIES, INC.
  • TABLE 75: AGILENT TECHNOLOGIES, INC., OPERATING SEGMENTS

List of Figures

  • FIG. 1: FLOW CYTOMETRY MARKET DEFINITION
  • FIG. 2: TOP FACTORS IMPACTING WORLD FLOW CYTOMETRY MARKET (2014-2022)
  • FIG. 3: TOP INVESTMENT POCKETS IN WORLD FLOW CYTOMETRY MARKET
  • FIG. 4: TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
  • FIG. 5: TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIG. 6: PORTERS FIVE FORCE ANALYSIS
  • FIG. 7: MARKET SHARE ANALYSIS, 2014
  • FIG. 8: TYPES OF PLATFORM
  • FIG. 9: NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2013)
  • FIG. 10: ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA AND MYELOMA (2014)
  • FIG. 11: ESTIMATED NEW CASES OF LEUKEMIA, BY TYPE, (2013)
  • FIG. 12: ESTIMATED NEW CASES AND DEATHS IN USA (2014)
  • FIG. 13: TOP TEN COUNTRIES WITH CANCER POPULATION (PER 100,000 PEOPLE) 2013
  • FIG. 14: PREVALENCE OF HIV/AIDS (TOP TEN COUNTRIES), 2013
  • FIG. 15: ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES USA (2014)
  • FIG. 16: DANAHER CORPORTAION, % REVENUE, BY BUSINESS SEGMENTS, (2014)
  • FIG. 17: DANAHER CORPORATION, % REVENUE, BY GEOGRAPHY (2014)
  • FIG. 18: SWOT ANALYSIS OF DANAHER CORPORATION
  • FIG. 19: EBIOSCIENCE SEGMENTS, REVENUE 2012-2014 ($MILLION)
  • FIG. 20: AFFYMETRIX INC.%REVENUE, BY GEOGRAPHY (2014)
  • FIG. 21: SWOT ANALYSIS OF AFFYMETRIX, INC.
  • FIG. 22: SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
  • FIG. 23: SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
  • FIG. 24: SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
  • FIG. 25: SWOT ANALYSIS OF SYSMEX CORPORATION
  • FIG. 26: BECTON, DICKINSON AND COMPANY, % REVENUE BY BUSINESS SEGMENT (2014)
  • FIG. 27: BECTON, DICKINSON AND COMPANY, % REVENUE, BY GEOGRAPHY (2014)
  • FIG. 28: SWOT ANALYSIS OF BECTON, DICKINSON AND COMPANY
  • FIG. 29: MERCK MILLIPORE, % REVENUE, BY BUSINESS SEGMENT (2014)
  • FIG. 30: SWOT ANALYSIS OF MERCK MILLIPORE
  • FIG. 31: LUMINEX CORPORATION,% REVENUE, BY GEOGRAPHY (2014)
  • FIG. 32: SWOT ANALYSIS OF LUMINEX CORPORATION
  • FIG. 33: THERMO FISHER SCIENTIFIC, INC.%REVENUE, BY BUSINESS UNITS, 2014 ($MILLION)
  • FIG. 34: THERMO FISHER SCIENTIFIC INC. REVENUE, 2012- 2014, ($MILLION)
  • FIG. 35: SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
  • FIG. 36: BIO-RAD LABORATORIES INC. REVENUE, 20122014, $MILLION
  • FIG. 37: BIO-RAD LABORATORIES% REVENUE, BY BUSINESS UNITS (2014)
  • FIG. 38: BIO-RAD LABORATORIES% REVENUE, BY GEOGRAPHY (2014)
  • FIG. 39: SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
  • FIG. 40: SWOT ANALYSIS OF MILTENYI BIOTEC GMBH
  • FIG. 41: AGILENT TECHNOLOGIES INC., %REVENUE BY BUSINESS UNITS, 2014 ($MILLION)
  • FIG. 42: AGILENT TECHNOLOGIES, INC.% REVENUE BY GEOGRAPHY (2014)
  • FIG. 43: SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC.
Back to Top